---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/41260906.md"
description: "Both Innodata and Innovent Biologics rose by around +11%, and Shopify also rose by about eight percentage points: Innodata secured a new Big Tech contract worth $51 million, and its pivot to AI data infrastructure is supported by its second-largest client in quantitative terms; Shopify is following the recovery narrative of the SaaS sector and AI recommendations, with no specific catalyst; Innovent Biologics is rebounding with the overall sentiment of the Hong Kong stock innovative drug sector this week.The nature of the three driving forces is different: Innodata's story relies on order fulfillment, Shopify leans towards valuation repair, and Innovent Biologics is more like a sector sentiment rebound. To distinguish which can continue, the focus should be on Innodata's Q2 customer concentration disclosure and Innovent's clinical progress."
datetime: "2026-05-29T10:41:57.000Z"
locales:
  - [en](https://longbridge.com/en/topics/41260906.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/41260906.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/41260906.md)
author: "[袋鼠](https://longbridge.com/en/profiles/27248405.md)"
---

# Both Innodata and Innovent Biologics rose by aroun…


### Related Stocks

- [INOD.US](https://longbridge.com/en/quote/INOD.US.md)
- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [SHOP.US](https://longbridge.com/en/quote/SHOP.US.md)